doi: 10.1016/0035-9203(95)90556-1.
Development of resistance to chloroquine by Plasmodium vivax in Myanmar
Affiliations
- PMID: 7660445
- DOI: 10.1016/0035-9203(95)90556-1
Item in Clipboard
Development of resistance to chloroquine by Plasmodium vivax in Myanmar
Trans R Soc Trop Med Hyg.
1995 May-Jun.
Abstract
Fifty patients with Plasmodium vivax infection were treated with the standard regimen of chloroquine phosphate (1500 mg over 3 d) followed by primaquine (45 mg immediately and then weekly for 8 weeks); 43 patients had sensitive infections but recrudescences of parasitaemia occurred between days 3 and 14 with RI, RII and RIII patterns in one, 3 and 3 patients, respectively. All the chloroquine-resistant cases were again treated with chloroquine (1500 mg) and no further recrudescence or relapse was detected on days 21 and 28. This study indicates that chloroquine is losing its efficacy against P. vivax in Myanmar.
Similar articles
-
Plasmodium vivax clinically resistant to chloroquine in Colombia.Am J Trop Med Hyg. 2001 Aug;65(2):90-3. doi: 10.4269/ajtmh.2001.65.90. Am J Trop Med Hyg. 2001. PMID: 11508397 Clinical Trial.
-
Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.Malar J. 2011 Feb 16;10:44. doi: 10.1186/1475-2875-10-44. Malar J. 2011. PMID: 21324161 Free PMC article.
-
Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.Acta Trop. 2010 Feb;113(2):105-13. doi: 10.1016/j.actatropica.2009.10.001. Epub 2009 Oct 14. Acta Trop. 2010. PMID: 19835832 Clinical Trial.
-
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.Lancet Infect Dis. 2018 Sep;18(9):1025-1034. doi: 10.1016/S1473-3099(18)30348-7. Epub 2018 Jul 20. Lancet Infect Dis. 2018. PMID: 30033231 Free PMC article.
-
Neglect of Plasmodium vivax malaria.Trends Parasitol. 2007 Nov;23(11):533-9. doi: 10.1016/j.pt.2007.08.011. Epub 2007 Oct 22. Trends Parasitol. 2007. PMID: 17933585 Review.
Cited by
-
Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial.Travel Med Infect Dis. 2020 Jul-Aug;36:101499. doi: 10.1016/j.tmaid.2019.101499. Epub 2019 Oct 8. Travel Med Infect Dis. 2020. PMID: 31604130 Free PMC article. Clinical Trial.
-
Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.Antimicrob Agents Chemother. 2015 Dec;59(12):7411-9. doi: 10.1128/AAC.00791-15. Epub 2015 Sep 21. Antimicrob Agents Chemother. 2015. PMID: 26392501 Free PMC article. Clinical Trial.
-
Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea.Am J Trop Med Hyg. 2009 Jun;80(6):902-4. Am J Trop Med Hyg. 2009. PMID: 19478246 Free PMC article.
-
Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.Malar J. 2017 Jul 10;16(1):281. doi: 10.1186/s12936-017-1912-y. Malar J. 2017. PMID: 28693552 Free PMC article.
-
Multidisciplinary Investigations of Sustained Malaria Transmission in the Greater Mekong Subregion.Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):138-151. doi: 10.4269/ajtmh.21-1267. Print 2022 Oct 11. Am J Trop Med Hyg. 2022. PMID: 36228909 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
